glutathione mutations in sclc patients

glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Unveiling the powerhouse: ASCL1-driven small

Name: glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Unveiling the powerhouse: ASCL1-driven small
Brand: www.ohotnichi-sezoni.com
SKU: 15106403274
Price: 25.37 USD
Availability: InStock
Rating: 4.1224 (30 reviews)

Unveiling the powerhouse: ASCL1 driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation Cancer & Metabolism Springer Nature Link Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer Frontiers Metabolic reprogramming in lung cancer and its clinical implication Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications The role of glutathione in the cellular response to cisplatin. (A) GSH Download Scientific Diagram

SKU: 15106403274 · From www.ohotnichi-sezoni.com

4.1

USD25.37 USD46.37

Pay in 4 interest-free payments of $6.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Antioxidants To minimize the negative effects of ROS generated by any pro-oxidant, endogenous defensive mechanisms called antioxidant defense (AD) system, which utilizes enzymatic and non-enzymatic mechanisms